Moderna Inc. MRNA shares,
rose 6.48% to $ 116.26 on Wednesday, in what proved to be a fully mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA,
increasing 1.44% to 30,829.40 and the NASDAQ Composite Index COMP,
falling 0.61% to 12,740.79. Moderna Inc. closed $ 62.24 below its 52-week high ($ 178.50), which the company reached on December 1.
The stock surpassed some of its competitors on Wednesday, such as AbbVie Inc. ABBV,
fell 0.86% to $ 105.58, Amgen Inc. AMGN,
rose 2.41% to $ 233.25, and AstraZeneca PLC ADR AZN,
rose 0.41% to $ 50.91. Turnover (21.4 M) remained 3.9 million below its average 50-day volume of 25.2 M.